Is biosimilarscouncil.org Safe? Security Analysis for Biosimilars Council
https://biosimilarscouncil.orgCheck if biosimilarscouncil.org is a scam or legitimate. Free security scan and reviews.
Below Healthcare avg (65)
10,000+
Domains scanned
500+
Security teams trust us
EveryPay
Secure checkout
Instant
Reports delivered
Get the professional PDF report for biosimilarscouncil.org
Export this security analysis as a professional PDF document, receive it via email, and access marketing intelligence data including contact emails and phone numbers. One-time purchase for lifetime access.
PDF Report & Export
PDF download, email delivery, unlock code
Marketing Intelligence
Contact emails, phone numbers & warm leads
Plan Comparison
| Feature | PDF Report | Marketing+ |
|---|---|---|
| Full security analysis | ||
| Professional PDF export | ||
| Email delivery | ||
| Lifetime access + unlock code | ||
| Contact emails & phones | — | |
| Marketing outreach data | — |
Already purchased?
Order summary
Digital reports are delivered immediately after payment. By continuing you acknowledge the withdrawal waiver described in our Returns & Refunds policy.
Secure payments processed via EveryPay. Prices in EUR; Incl. 21% VAT.
SEQ SIA
Lastadijas 12 k-3, Riga, Latvia, LV-1050
Reg. No. 40203410806 • VAT LV40203410806
Support: guard@offseq.com • +371 2256 5353
AI Summary
The Biosimilars Council is a U.S.-based healthcare advocacy organization focused on promoting biosimilar medicines. It operates as a division of the Association for Accessible Medicines and serves as a leading resource for biosimilar education, policy advocacy, and industry research. The website reflects a mature digital presence with rich content including press releases, reports, and event information targeting healthcare professionals, policymakers, and industry stakeholders. The organization positions itself as a key player in shaping biosimilar policy and market development in the U.S. Technically, the website is built on WordPress with modern plugins and frameworks such as WPBakery Page Builder and Yoast SEO. It integrates multiple third-party analytics and marketing tools including Google Analytics, Facebook Pixel, LinkedIn Insight Tag, and Twitter tracking. Hosting appears to be on a reputable managed WordPress platform, likely WP Engine, with Cloudflare DNS services. The site is mobile optimized and SEO friendly, though accessibility features are basic. From a security perspective, the site enforces HTTPS and uses domain locking status codes to protect domain integrity. However, DNSSEC is not enabled, and there is no visible advanced security policy or incident response information published. Privacy compliance is limited, with no explicit privacy or cookie policies or consent mechanisms detected, representing a compliance gap. No contact emails or phone numbers are publicly listed, only contact forms. Overall, the site is professional and trustworthy with a strong business credibility score but could improve privacy compliance and security transparency. Strategic recommendations include publishing comprehensive privacy and cookie policies, enabling DNSSEC, and adding security and incident response disclosures to enhance trust and compliance.
Detected Technologies
14 urgent findings need attention
14 high
- + 6 more findings in the full report below
Keep biosimilarscouncil.org under constant watch
Guard tracks your live infrastructure daily: certificate expiry, DNS & mail authentication drift, uptime changes, subdomain inventory, and unexpected tracker or content shifts. A full timeline captures every diff so you can prove remediation and spot regressions instantly.
Security drift alerts
Risk score drops, new high-severity issues, and header hardening gaps
Compliance watch
GDPR / NIS2 posture changes with governance evidence snapshots
Infrastructure surface
Unexpected open services, SSL expiry, DNS & email authentication changes
Content & tracker intelligence
Marketing tech shifts, analytics drift, and AI recommendation updates
Cancel anytime. Alerts sent to the contacts you choose. Unlock the full report to view historical timelines and alerts.
Security Headers
8 findings
15/100
GDPR Compliance
4 findings
35/100
NIS2 Compliance
9 findings
2/100
Email Security
4 findings
70/100
🧠AI Business Intelligence
Technology stack, business insights, and market analysis powered by AI.
Business Intelligence
Market & Strategic Analysis
The Biosimilars Council operates in the healthcare sector as an important advocacy and resource organization. It leverages partnerships with regulatory bodies like the FDA and industry research firms such as IQVIA to provide authoritative content and influence policy. Its business model centers on education, advocacy, and event hosting to support biosimilar adoption. The organization targets healthcare professionals, policymakers, and industry stakeholders, positioning itself as a market leader in biosimilar advocacy. The domain age and content maturity indicate a stable and established presence. The partnership ecosystem includes reputable healthcare and regulatory entities, enhancing its market credibility.
Extracted Contact Information
Marketing Intelligence Data
Physical Addresses (1)
Security Posture Analysis
Comprehensive Security Assessment
The website demonstrates a moderate security posture with HTTPS enforced and domain registration locked against unauthorized changes. However, the absence of DNSSEC and lack of published security policies or incident response contacts limit its security maturity. The use of multiple third-party tracking scripts introduces potential privacy risks. No critical vulnerabilities or exposed sensitive data were detected in the content. The site would benefit from implementing advanced security headers such as Content Security Policy and publishing clear security and privacy documentation to improve compliance and user trust.
Strategic Recommendations
Priority Actions for Security Improvement
Publish a comprehensive privacy policy and cookie policy with explicit GDPR compliance statements.
✨Observations
AI-powered comprehensive website and business analysis.
AI-Enhanced Website Analysis
Business Insights
Biosimilars Council
The Biosimilars Council, a division of the Association for Accessible Medicines, works to ensure a positive future for biosimilar medicines.
good
consistent
Technical Stack
moderate
good
basic
good
Security Assessment
- HTTPS enforced
- Domain locked with multiple EPP status codes
- Use of Cloudflare DNS
Analytics & Tracking
Advertising & Marketing
Website Quality Assessment
Key Observations
Website is a professional healthcare advocacy site focused on biosimilars.
Get this report delivered to your inbox
Receive a summary of the biosimilarscouncil.org security findings by email. Quick and easy to share with decision makers.
🛡️Security Headers
HTTP security headers analysis and recommendations.
Security Headers
HTTP security headers analysis
Missing Strict-Transport-Security header
HIGHForces HTTPS connections
Missing X-Frame-Options header
HIGHPrevents clickjacking attacks
Missing X-Content-Type-Options header
MEDIUMPrevents MIME type sniffing
Missing Content-Security-Policy header
HIGHControls resources the browser is allowed to load
Missing X-XSS-Protection header
MEDIUMLegacy XSS protection (deprecated but still recommended)
Missing Referrer-Policy header
LOWControls referrer information sent with requests
Missing Permissions-Policy header
MEDIUMControls browser features and APIs
Sensitive data may be cached
LOWCache-Control header should include "no-store" for sensitive pages
👤GDPR Compliance
Privacy and data protection assessment under GDPR regulations.
GDPR Compliance
Privacy and data protection assessment
No Privacy Policy found
HIGHGDPR requires a clear and accessible privacy policy
No Cookie Policy found
HIGHGDPR requires clear information about cookie usage
No Cookie Consent Banner found
HIGHGDPR requires explicit consent for non-essential cookies
Third-party services without privacy policy
HIGHDetected services: Google Analytics, Facebook, Twitter, LinkedIn, YouTube, Google APIs
GDPR Compliance Analysis
🛡️NIS2 Compliance
Network & Information Security Directive compliance assessment.
NIS2 Compliance
Network & Information Security Directive
No information security framework found
HIGHNIS2 requires documented cybersecurity and information security measures
No vulnerability disclosure policy
MEDIUMNIS2 encourages coordinated vulnerability disclosure
No security policy documentation found
HIGHNIS2 requires documented cybersecurity governance and risk management
No incident response procedures found
HIGHNIS2 requires documented incident response and business continuity plans
No business continuity planning found
MEDIUMNIS2 emphasizes operational resilience and business continuity
No security contact information
HIGHNIS2 requires clear incident reporting channels
No vulnerability reporting mechanism
MEDIUMClear vulnerability reporting supports coordinated disclosure
No NIS2 reference found
LOWConsider explicitly mentioning NIS2 compliance efforts
Critical sector without clear security compliance
HIGHDetected sectors: energy, transport, health, digital
Need this report as a PDF?
Download the complete biosimilarscouncil.org security analysis as a professional PDF. Share it with your team, clients, or stakeholders.
📧Email Security
SPF, DKIM, and DMARC validation and email security assessment.
Email Security
SPF, DKIM, and DMARC validation
No DKIM record found
MEDIUMDKIM adds cryptographic signatures to emails
No BIMI Record
LOWBIMI displays brand logos in email clients
No MTA-STS Policy
MEDIUMMTA-STS enforces TLS for email delivery
No TLS-RPT Record
LOWTLS-RPT provides reporting for email TLS issues
SPF Details
🏆SSL/TLS Security
Certificate validity and encryption analysis.
SSL/TLS Security
Certificate validity and encryption analysis
Weak Protocols Supported
HIGHServer supports weak protocols: TLSv1.1
Certificate Transparency Not Implemented
LOWCertificate is not logged in Certificate Transparency logs
SSL Certificate Expires Within 90 Days
MEDIUMSSL certificate expires in 75 days
Weak SSL Key Length
HIGHSSL certificate uses 256-bit key, which is considered weak
Partial SSL/TLS Assessment
LOWCompleted 3 of 4 security checks due to time constraints
Protocol Support
OCSP Status
📊DNS Health
DNS configuration and security assessment.
DNS Health
DNS configuration and security assessment
DNSSEC Not Enabled
MEDIUMDNSSEC is not configured for this domain
No DMARC Record
MEDIUMDMARC policy not configured
Domain Registration Details
- •Privacy/proxy registration detected
DNS Records
DNSSEC Status
DNS Performance
SPF Analysis
⚡Network Security
Port scanning and network exposure analysis.
Network Security
Port scanning and network exposure analysis
Good Network Security Posture
LOWNo unnecessary services detected on common risky ports
How does biosimilarscouncil.org compare?
See how biosimilarscouncil.org stacks up against similar websites in the same industry.
🔧Technical Analysis
Detailed technical findings and analysis from AI assessment.
Technical Analysis
Comprehensive security assessment findings
Additional Findings
Download the biosimilarscouncil.org report as PDF
Get the complete analysis in a shareable PDF format, delivered instantly to your email with lifetime access.
PDF Report & Export
PDF download, email delivery, unlock code
Marketing Intelligence
Contact emails, phone numbers & warm leads
Plan Comparison
| Feature | PDF Report | Marketing+ |
|---|---|---|
| Full security analysis | ||
| Professional PDF export | ||
| Email delivery | ||
| Lifetime access + unlock code | ||
| Contact emails & phones | — | |
| Marketing outreach data | — |
Already purchased?
Order summary
Digital reports are delivered immediately after payment. By continuing you acknowledge the withdrawal waiver described in our Returns & Refunds policy.
Secure payments processed via EveryPay. Prices in EUR; Incl. 21% VAT.
SEQ SIA
Lastadijas 12 k-3, Riga, Latvia, LV-1050
Reg. No. 40203410806 • VAT LV40203410806
Support: guard@offseq.com • +371 2256 5353
Scan your own website
Liked the biosimilarscouncil.org report? Run the same comprehensive security analysis on your domain — free, instant, and no sign-up required.
Or browse our directory of >10,000 scanned websites.
How did we do?
Your feedback directly shapes our roadmap. Rate the quality of this report, leave an optional comment, and let us know if you want our security specialists to follow up.
What others say about biosimilarscouncil.org
Share your experience to help others make informed decisions. We verify every review by email and publish it once our moderation team approves it.
Community rating
—out of 5
0 reviews published